Category Archives: Jim’s Corner

This month, BIO is leading a delegation of biopharma CEOs to China for meetings with members of the Chinese biotech community and government leaders. The mission illustrates a strong commitment on behalf of the western biotechnology industry to encourage China to strengthen its support for biotech innovation and take steps to enhance greater investment and collaboration with companies in China. The series of meetings between China’s local industry and government leaders and biotech CEOs will Read More >

I have had epilepsy since I was fifteen. Back in the 1950s many people—my parents included— believed that my “fits” were caused by a spiritual force. Growing up with this neurological disorder and dealing with the misinformation surrounding its causes and treatment was difficult. My disability also got me kicked out of seminary. Fortunately, since then, the world has changed for the better for those of us with disabilities. It wasn’t until I was a Read More >

President Obama is right to focus on innovation and jobs in his State of the Union speech tonight, particularly the need to create and fill new jobs to compete in an increasing competitive global marketplace. Notably, the President also called for investments in biomedical research and clean energy technologies. There’s no industry better poised to meet these challenges than biotechnology. Nationwide, our industry directly employs more than 1.4 million people and indirectly generates jobs for Read More >

The ability of BIO members to heal, fuel, and feed the world depends on having an economic and public policy environment that supports their work. The Therapeutic Discovery Project (TDP) program, enacted in 2010, is an example of the type of policies necessary to spur continued medical innovation, while at the same time protecting and growing high-paying U.S. jobs. The TDP program provided $1 billion in research grants and credits for small biotech companies pursuing Read More >

The biotechnology industry works to translate life science into solutions for healing previously untreatable medical conditions, feeding the world’s growing population, and fueling mobility and economic growth using cleaner manufacturing processes. These high aspirations have always brought unique challenges to biotechnology companies, and in the wake of the recent worldwide recession those challenges have become particularly difficult. But the need for innovation in health care is clear and present. The number of unmet public health Read More >